AtriCure (ATRC) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on AtriCure (ATRC) is Neutral.

The composite score behind that read is +0.15, weighing +0.24 of bullish evidence against -0.23 bearish.

AtriCure last closed at $55.81, +5.62% on the session.

Against the IVW growth benchmark the position is +4.82% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 60%.

5 graded predictions for ATRC so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks AtriCure in the 2nd percentile on valuation and the 43rd percentile on return on equity, where 100 is best.

AtriCure is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $2.69B.

StockMap tracks AtriCure as the 40th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite AtriCure ranks 4th of 140 in the group, against a group median of -0.03.